US approves updated Pfizer, Moderna shots targeting Omicron / Photo: © AFP/File
-
Trump turns history on head with Putin invitation to key US base
-
Gauff dominates Bronzetti to reach Cincinnati last eight
-
UN warns Russia, Israel of conflict sex crimes listing risk
-
Flood kills 46 in Indian Kashmir mountain village
-
Germany sacks rail chief with train network in crisis
-
Trump says Putin summit could fail, promises Ukraine say
-
Lyles v Thompson in re-run of Olympic 100m final in Silesia
-
LA 2028 to sell venue name rights in Olympic first
-
Solomon Islands says China not influencing diplomatic decisions
-
Flood kills 37 in Indian Kashmir mountain village
-
US stocks drop as producer inflation surges
-
Greenpeace stages Anish Kapoor art protest on UK gas platform
-
US producer inflation highest in three years in July
-
Greek firefighters beat back wildfires
-
Serbia's political crisis escalates into clashes
-
Australia recall O'Connor to face champions South Africa
-
Kremlin says Putin, Trump to hold 'one-on-one' talks in Alaska
-
Stocks diverge as bitcoin hits record high
-
Spain suffers third wildfire death, Greece beats back flames
-
Liverpool 'agree deal' for Parma prospect Leoni
-
Foreign NGOs say new Israeli rules keep them from delivering Gaza aid
-
Japan's grand tea master Sen Genshitsu dies at 102: reports
-
Water shortages plague Beirut as low rainfall compounds woes
-
Germany's Thyssenkrupp cuts targets as US tariffs weigh
-
Brady didn't understand football, says Rooney after 'work ethic' jibe
-
Greek firefighters make progress against wildfires
-
UK economy slows less than feared after tariffs
-
Markets mixed as bitcoin hits new high
-
PSG begin French title defence as Pogba returns home and Paris FC step up
-
At least 40 dead in Sudan's worst cholera outbreak in years: MSF
-
Zelensky in London to meet PM ahead of US-Russia summit
-
French dictionary gets bad rap over Congolese banana leaf dish
-
Alaska: a source of Russian imperial nostalgia
-
Last chance saloon for global plastic pollution treaty
-
India to bid for Commonwealth Games as part of Olympic push
-
North Korea denies removing border loudspeakers
-
Despite risks, residents fight to protect Russian national park
-
Asian markets mixed as bitcoin surges to new high
-
War-weary Ukrainians find solace by frontline lake
-
Okinawa a reluctant host for US troops 80 years after WWII
-
Alonso's Real Madrid start La Liga with fresh energy
-
Liverpool splash out to secure status as Premier League's top dogs
-
Hong Kong court postpones closing arguments in Jimmy Lai trial
-
Top Japanese fighter retires to support comatose boxer brother
-
Boars, Butterflies or Bees? Public to name Papua New Guinea's NRL team
-
Defending champions Sinner, Sabalenka reach Cincinnati quarters
-
Bolivia presidential hopefuls make last push for votes
-
Trump orders space regulations eased in win for Musk
-
From Snoop Dogg to Tom Brady, stars flock to English second-tier clubs
-
Inside Trump's 'Alligator Alcatraz': detainees allege abuse in a legal black hole
NYSE - LSE
| RBGPF | 0% | 73.08 | $ | |
| RYCEF | 1.01% | 14.85 | $ | |
| CMSC | -0.39% | 23.08 | $ | |
| BTI | 0.47% | 57.38 | $ | |
| BCC | -2.95% | 85.62 | $ | |
| GSK | -0.37% | 38.985 | $ | |
| RIO | -2.23% | 62.185 | $ | |
| SCS | -0.89% | 16.215 | $ | |
| NGG | 1.31% | 71.465 | $ | |
| VOD | -0.22% | 11.625 | $ | |
| RELX | -0.07% | 47.735 | $ | |
| CMSD | -0.34% | 23.63 | $ | |
| JRI | 0.22% | 13.43 | $ | |
| BCE | 0.69% | 25.285 | $ | |
| AZN | 0.38% | 78.235 | $ | |
| BP | 0.31% | 34.415 | $ |
US approves updated Pfizer, Moderna shots targeting Omicron
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.
The two updated booster shots aimed at providing "better protection against Covid-19 caused by the Omicron variant" are approved for people age 12 and above for the Pfizer shot and 18 and older for Moderna, the Food and Drug Administration (FDA) said in a statement.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States and which the FDA predicts will circulate in the coming months.
Earlier this summer the US health department announced it had purchased 105 million doses from Pfizer and 66 million from Moderna for use over the fall and winter.
The vaccines have yet to be recommended by the Centers for Disease Control and Prevention, the nation's health protection agency. But an independent panel of experts is scheduled to be convened by the CDC on Thursday to discuss the updates.
CDC director Rochelle Walensky will be in charge of giving the final green light.
The new versions of the vaccines could potentially be available in the United States as early as next week.
"Receiving a booster that specifically targets the Omicron BA.4/.5 variant, currently the most prevalent strain of SARS-CoV-2, is an important public health measure that people can take to help protect themselves, especially as we head into a season filled with indoor gatherings," Moderna chief executive Stephane Bancel said in a statement.
The vaccines currently in circulation target the initial strain of the virus that first appeared in Wuhan, China. But they have gradually proven to be less effective against the variants that have appeared over time, due to rapid evolution of the virus.
In contrast to the Alpha and Delta variants, which eventually waned, Omicron and its subvariants have come to dominate infections worldwide in 2022.
Pfizer and Moderna have also filed for approval of their updated vaccines with the European Medicines Agency.
J.Bergmann--BTB
